Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

WSB2 Inhibitors

WSB2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the WD repeat and SOCS box-containing protein 2 (WSB2). WSB2 is part of the E3 ubiquitin ligase complex, a multi-protein system that plays a crucial role in the ubiquitination process, which marks proteins for degradation by the proteasome. By inhibiting WSB2, these compounds disrupt its involvement in the ubiquitination pathway, leading to altered protein stability and turnover within cells. The inhibition of WSB2 can result in the modulation of various cellular processes that depend on protein degradation, such as signal transduction, cell cycle regulation, and protein quality control. This makes WSB2 inhibitors of interest in studies focused on understanding the biological mechanisms of protein homeostasis and degradation.

Structurally, WSB2 inhibitors can vary widely, but they typically contain molecular features that allow for specific binding to the WSB2 protein, effectively blocking its ability to interact with its substrate or other components of the E3 ligase complex. Some inhibitors may bind directly to the WD repeat domains, which are important for protein-protein interactions, while others might target the SOCS box domain, which mediates the recruitment of ubiquitin-conjugating enzymes. The specificity of these inhibitors is crucial for studying the precise roles of WSB2 in different biological pathways without interfering with the functions of other proteins in the ubiquitin-proteasome system. This specificity allows researchers to delineate the unique contributions of WSB2 to cellular functions and its regulatory networks, providing deeper insights into the molecular basis of protein degradation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Could inhibit proteasomal activity, possibly influencing WSB2 protein levels.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

May affect lysosomal degradation, potentially impacting WSB2 protein turnover.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

Might inhibit autophagy, potentially affecting WSB2 degradation.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Could inhibit vacuolar H+-ATPase, influencing lysosomal function and WSB2 degradation.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Might inhibit protein synthesis, affecting WSB2 protein levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

May inhibit transcription, affecting WSB2 mRNA levels.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that might influence WSB2 expression through MAPK pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor that could affect WSB2 expression via stress response pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

ERK pathway inhibitor that might influence WSB2 expression regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that could impact WSB2 expression through AKT signaling pathways.